RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38α mitogen-activated protein kinase (p38α(MAPK))

144Citations
Citations of this article
48Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A novel ribosomal S6 kinase (RSK) family member, RSK-B, was identified in a p38α(MAPK)-baited intracellular interaction screen. RSK-B presents two catalytic domains typical for the RSK family. The protein kinase C-like N- terminal and the calcium/calmodulin kinase-like C-terminal domains both contain conserved ATP-binding and activation consensus sequences. RSK-B is a p38α(MAPK) substrate, and activated by p38α(MAPK) and, more weakly, by ERK1. RSK-B phosphorylates the cAMP response element-binding protein (CREB) and c-Fos peptides. In intracellular assays, RSK-B drives cAMP response element- and AP1-dependent reporter expression. RSK-B locates to the cell nucleus and co-translocates p38α(MAPK). In conclusion, RSK-B is a novel CREB kinase under dominant p38α(MAPK) control, also phosphorylating additional substrates.

Cite

CITATION STYLE

APA

Pierrat, B., Da Silva Correia, J., Mary, J. L., Tomás-Zuber, M., & Lesslauer, W. (1998). RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38α mitogen-activated protein kinase (p38α(MAPK)). Journal of Biological Chemistry, 273(45), 29661–29671. https://doi.org/10.1074/jbc.273.45.29661

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free